New Trends in Basic and Clinical Research of Glaucoma: A Neurodegenerative Disease of the Visual System – Part B
- 1st Edition, Volume 221 - October 21, 2015
- Latest edition
- Editors: Giacinto Bagetta, Carlo Nucci
- Language: English
New Trends in Basic and Clinical Research of Glaucoma: A Neurodegenerative Disease of the Visual System - Part B is the latest volume from Progress in Brain Research focusing on n… Read more
New Trends in Basic and Clinical Research of Glaucoma: A Neurodegenerative Disease of the Visual System - Part B is the latest volume from Progress in Brain Research focusing on new trends in basic and clinical research of glaucoma. This established international series examines major areas of basic and clinical research within neuroscience, as well as emerging subfields.
- This well-established international series examines major areas of basic and clinical research within neuroscience, as well as emerging subfields
Neuroscientists, psychologists, neurologists
- Preface
- Part B
- Chapter 1: Molecular biomarkers in primary open-angle glaucoma: from noninvasive to invasive
- Abstract
- 1 Introduction: What is a Biomarker?
- 2 Defining Biomarkers
- 3 Noninvasive Biomarkers in Primary Open-Angle Glaucoma
- 4 Minimally Invasive Biomarkers in Primary Open-Angle Glaucoma
- 5 Invasive Biomarkers in Primary Open-Angle Glaucoma
- 6 Molecular Biomarkers in Clinical Practice: Is Translation Feasible?
- 7 Summary and Conclusions
- Chapter 2: Cerebrospinal fluid pressure in the pathogenesis of glaucoma
- Abstract
- 1 Introduction
- 2 Anatomy and Dynamics of the Optic Nerve Head in Relationship to the Retrobulbar CSF Space
- 3 Intraocular Pressure
- 4 Relationship Between CSFP and IOP and Its Dynamics
- 5 CSFP, TLPD, and IOP: glaucomatous Optic Neuropathy
- 6 Limitations
- 7 Methods for Determining CSFP
- 8 CSFP and Retinal and Choroidal Vein Pressure
- Chapter 3: Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system
- Abstract
- 1 Background
- 2 Glaucoma and AD
- 3 Glaucoma and PD
- 4 Glaucoma and LHON
- 5 Glaucoma and Cerebrovascular Diseases
- 6 Discussion
- Acknowledgment
- Chapter 4: New technologies for measuring intraocular pressure
- Abstract
- 1 Tonometry
- 2 Applanation Tonometry
- 3 Dynamic Contour (Pascal) Tonometer
- 4 Rebound Tonometry
- 5 Digital GAT
- 6 Ocular Response Analyzer
- 7 Transpalpebral Tonometers
- 8 Noncontact Corvis ST
- 9 SENSIMED Triggerfish® Contact Lens Sensor
- Chapter 5: Emerging risk factors for glaucoma onset and progression
- Abstract
- 1 Introduction
- 2 Ocular Risk Factors
- 3 Systemic Risk Factors
- 4 Risk Calculators
- 5 Summary
- Chapter 6: Strategies to improve early diagnosis in glaucoma
- Abstract
- 1 Detecting Early Functional Change
- 2 Detecting Structural Change
- 3 Combining Information from Structural and Functional Tests
- 4 Conclusion
- Acknowledgments
- Chapter 7: How to detect progression in glaucoma
- Abstract
- 1 Introduction
- 2 General Concepts
- 3 Functional Progression
- 4 Structural Progression
- 5 Combining Progression Techniques
- 6 Conclusion
- Acknowledgments
- Chapter 8: Brain imaging in glaucoma from clinical studies to clinical practice
- Abstract
- 1 Background
- 2 Conventional MRI
- 3 Diffusion Imaging
- 4 Functional Imaging
- 5 Voxel-based Morphometry
- 6 Magnetic Resonance Spectroscopy
- Chapter 9: Primary congenital glaucoma
- Abstract
- 1 Epidemiology
- 2 Genetics
- 3 Pathogenesis
- 4 Presentation
- 5 Differential Diagnosis
- 6 Management
- 7 Key Points
- Acknowledgments
- Chapter 10: New findings in the diagnosis and treatment of primary angle-closure glaucoma
- Abstract
- 1 Introduction
- 2 Epidemiology
- 3 Ocular Risk Factors
- 4 Pathophysiology
- 5 Classification
- 6 Ophthalmic Examination
- 7 Management
- 8 Acute PAC
- 9 Particular Conditions
- Chapter 11: Advance in the pathogenesis and treatment of normal-tension glaucoma
- Abstract
- 1 Introduction
- 2 Advance in the Pathogenesis of Normal-Tension Glaucoma
- 3 Advance in the Treatment of Normal-Tension Glaucoma
- 4 Summary and Conclusion
- Chapter 12: Exfoliative glaucoma: new evidence in the pathogenesis and treatment
- Abstract
- 1 Introduction
- 2 Pathophysiology and Genetic Features
- 3 Geographic and Epidemiologic Features
- 4 Clinical Outcome and Treatment
- Chapter 13: Uveitis and glaucoma: new insights in the pathogenesis and treatment
- Abstract
- 1 Introduction
- 2 Pathogenesis
- 3 Treatment
- 4 Conclusion
- Chapter 14: Glaucoma risks in advanced corneal surgery
- Abstract
- 1 Mechanism of Steroid-Induced Glaucoma
- 2 Lamellar and Penetrating Keratoplasty
- 3 Glaucoma Risk and Penetrating Keratoplasty
- 4 Glaucoma Risk and Deep Anterior Lamellar Keratoplasty
- 5 Glaucoma Risk and Descemet Stripping-Automated Endothelial Keratoplasty
- 6 Glaucoma Risk and Descemet Membrane Endothelial Keratoplasty
- 7 Post-Corneal Graft Glaucoma Treatment
- 8 Keratoprosthesis
- 9 Laser-Assisted In Situ Keratomileusis—Interface Fluid Syndrome
- 10 Urrets-Zavalia Syndrome
- 11 Conclusions
- Chapter 15: Twenty-four hour efficacy of glaucoma medications
- Abstract
- 1 Introduction
- 2 24-Hour Efficacy of Monotherapies
- 3 24-Hour Efficacy of Combined Therapy
- 4 Combinations of Prostaglandin Analogues with β-Blockers
- 5 Combinations of Carbonic Anhydrase Inhibitors with β-Blockers
- 6 Combinations of Carbonic Anhydrase Inhibitors with a Prostaglandin Analogue
- 7 Combination of an Alpha-2 Agonist and a β-Blocker
- 8 Combination of an Alpha-2 Agonist and a Carbonic Anhydrase Inhibitor
- Chapter 16: Modulation of wound healing in glaucoma surgery
- Abstract
- 1 Introduction
- 2 Wound Healing Response
- 3 Modulation of Wound Healing: Clinical Practice
- 4 New Methods and Upcoming Trends in Wound Healing Modulation
- 5 Conclusions
- Chapter 17: Emerging surgical therapy in the treatment of glaucoma
- Abstract
- 1 Introduction
- 2 Ab Externo and Ab Interno Procedures
- 3 Enhancing Outflow Procedures
- 4 Reducing Aqueous Production Procedures
- 5 Conclusions
- Chapter 18: Visual disability and quality of life in glaucoma patients
- Abstract
- 1 Introduction
- 2 Methods for Correlating Visual Disability and Quality of Life
- 3 Disabilities in Glaucoma
- 4 Rehabilitation in Glaucoma
- 5 Conclusion
- Index
- Contents of Previous Volumes
- Edition: 1
- Latest edition
- Volume: 221
- Published: October 21, 2015
- Language: English
GB
Giacinto Bagetta
Giacinto Bagetta is Professsor of Pharmacology and works in the Department of Pharmacy, Health Science and Nutrition
at University of Calabria, Arcavata di Rende, Italy.
Affiliations and expertise
Professsor of Pharmacology, University of Calabria, Arcavata di Rende, ItalyCN
Carlo Nucci
Carlo Nucci is Professor of Ophthalmology in the Ophthalmology Unit, Department of Experimental Medicine at the University of Rome Tor Vergata, Italy.
Affiliations and expertise
Professor of Ophthalmology, Ophthalmology Unit, Department of Experimental Medicine, University of Rome Tor Vergata, ItalyRead New Trends in Basic and Clinical Research of Glaucoma: A Neurodegenerative Disease of the Visual System – Part B on ScienceDirect